Thyroid and Parathyroid Diseases: Advances in Molecular Imaging

Dear Colleagues,

Thyroid and parathyroid disorders affect millions of people worldwide, yet accurate diagnosis and personalized treatment remain challenging due to the complex heterogeneity of these conditions. Advancements in radiopharmaceutical chemistry, hybrid imaging, and AI-driven analytics are improving endocrine diagnostics. For specialists handling thyroid and parathyroid diseases, whether diagnosing, planning surgery, guiding therapy, analyzing specimens, or delivering targeted treatments, this Special Issue brings together the frontiers of innovation, with real clinical relevance. We invite high-quality submissions in the following different areas of interest:

Molecular Tracers and Biomarkers

Emerging radiopharmaceuticals (e.g., 18F-tetrafluoroborate, 68Ga-Trivehexin, 18F-choline, PSMA analogs) for improved detection, staging, and risk stratification in thyroid malignancies and enhanced lesion detection in hyperparathyroidism.

State-of-the-Art Imaging Modalities

PET/CT and PET/MRI enhancements for superior lesion detection.

4D CT/MRI, SPECT/CT, and ultrasound‑PET fusion tailored for surgical precision.

AI and Radiomics

Cutting-edge tools for image interpretation, quantification, and predictive modeling to boost diagnostic confidence and efficiency.

Theranostics and Personalized Treatment

Dual imaging-therapy strategies (e.g., PSMA-targeted PET and 177Lu-based therapy) for individualized care.

Integration of imaging biomarkers into treatment pathways.

This Special Issue welcomes a wide range of article types, and we particularly encourage submissions of original research, systematic reviews, and meta-analyses.

Join us in shaping the future of thyroid and parathyroid imaging by contributing to this timely and impactful collection!

Dr. Petra Petranovic Ovcaricek
Prof. Dr. Luca Giovanella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.